Study Points
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
Study Points
Click on any objective to view test questions.
- Review the pertinent history surrounding the discovery and early administration of neuromuscular blocking agents.
- Outline the anatomy and physiology of the neuromuscular junction.
- Identify commonly used neuromuscular blockers.
- Discuss the use and effects of benzylisoquinolinium nondepolarizing neuromuscular blocking agents.
- Describe the use and effects of amino steroid nondepolarizing neuromuscular blockers.
- Identify the crucial effects and side effects of succinylcholine, listing both relative and absolute contraindications to its use.
- Analyze approaches to monitoring neuromuscular blockade.
- Evaluate the effects and use of traditional agents used to reverse neuromuscular blockade.
- Discuss the reversal agent sugammadex.
- Analyze the role of neuromuscular blockers in various patient populations.
What is the archetypal neuromuscular blocking agent?
The first discovery of neuroblocking effects of a substance is believed to have occurred in
The small spaces between the Schwann cells are called the
Which of the following statements regarding the anatomic structures of the neuromuscular junction is TRUE?
Acetylcholine
The operant part of the skeletal muscle is the
Which of the following types of neuromuscular blocking agents has a structure similar to acetylcholine?
Which of the following is a depolarizing neuromuscular blocking agent?
The ED95 is the estimated dose at which
Amino-steroid nondepolarizing agents
What is the intubating dose of pancuronium?
The key to determining the duration of pancuronium's effects is a patient's
Rocuronium is typically used in the
Which of the following statements regarding rocuronium in elderly patients is TRUE?
Vecuronium undergoes elimination in the
Which of the following is the most commonly used benzylisoquinolinium-based neuromuscular blocking agent?
In large doses, laudanosine (a metabolite of atracurium) has rarely been associated with
Which of the following patient groups should not receive atracurium?
After an intubating dose of succinylcholine, a patient will return to normal in
All of the following are potential side effects of succinylcholine, EXCEPT:
Fluoride-resistant cholinesterase has what impact on succinylcholine duration of action?
The initial onset of malignant hyperthermia following succinylcholine administration is characterized by
In obese patients, succinylcholine dosage should be calculated based on
According to the Eastern Association for the Surgery of Trauma, what is the neuromuscular blocking agent of choice for use securing the airway via emergency intubation in the prehospital setting?
Levels and degrees of neuromuscular blockade can be monitored via
Most commonly, neuromuscular blockade is monitored on the
Two twitches seen during train of four stimulation after the administration of a nondepolarizing neuromuscular blocking agent indicate
Of the following, which agent is used most frequently for the reversal of neuromuscular blockade induced by a nondepolarizing agent?
Sugammadex was designed to have a specific affinity for
ICU-acquired weakness may develop following the use of muscle relaxants in the ICU. What approach can help avoid this phenomenon?
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.